menu
    • menu

    Company profile for Abbott Laboratories

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We understand that the first step to living your best life is good health. Everything we make is designed to help you do just that. That’s our commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abbott LaboratoriesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Abbott Park Road, Abbott Park, IL 60064 - (224) 667-6100
    Telephone
    Telephone
    +91-22-3816 2000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abbott.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abbott-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AbbottNews

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 4826

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    FDA’s landmark approvals of BMS’ schizo med, Madrigal’s MASH drug, US$ 16.5 bn Catalent buyout make it to top 10 news of 2024

    FDA’s landmark approvals of BMS’ schizo med, Madrigal’s MASH drug, US$ 16.5 bn Catalent buyout make it to top 10 news of 2024

    The year 2024 was marked by some landmark drug approvals in the areas of schizophrenia, metabolic dysfunction-associated steatohepatitis (MASH), chronic obstructive pulmonary disease (COPD) and Alzheimer’s disease. The incoming Trump administration, monkeypox outbreak and drug price negotiations in the US also created big news. Here is PharmaCompass’ compilation of the top 10 news from Phispers of 2024. I. BMS’ US$ 14 bn Karuna bet pays off with landmark FDA approval for schizophrenia med Cobenfy The US Food and Drug Administration’s groundbreaking approval of Bristol Myers Squibb’s Cobenfy to treat schizophrenia has made it to our number one spot. BMS had acquired Cobenfy through its US$ 14 billion purchase of Karuna Therapeutics, announced in December 2023. Cobenfy is the first-ever antipsychotic that targets cholinergic receptors. Cobenfy’s new approach has experts excited. Its peak sales are expected to come in at US$ 7.5 billion a year. While BMS’ Karuna buyout paid off, AbbVie’s US$ 8.7 billion acquisition of Cerevel Therapeutics was dampened when their lead candidate and schizophrenia drug emraclidine failed to meet phase 2 endpoints in two pivotal trials. II. 2024’s biggest deal, US$ 16.5 bn Catalent buyout by Novo’s parent, cleared after intense scrutiny  On number two spot is Novo Nordisk Foundation’s acquistion of Catalent via its investment arm Novo Holdings for US$ 16.5 billion, announced in February 2024. Novo Holdings plans to sell three of Catalent’s “fill-finish” sites to Novo Nordisk for US$ 11 billion. Easily the biggest biopharma acquisition of last year, the deal  faced criticism from lawmakers and consumer groups for its potential anti-competitive effects, particularly in the glucagon-like peptide-1 (GLP-1) drug market. Its main competitor Eli Lilly called for scrutiny by competition regulators. However, in December, both the EU regulator and the US Federal Trade Commission gave it the greenlight. III. Madrigal’s Rezdiffra becomes first FDA-approved drug for liver disease MASH For quite some time, the drug development field for the liver condition MASH had been a graveyard for failed programs. In 2024, the field celebrated a hurrah moment when Madrigal’s oral drug Rezdiffra became the first treatment in the US for adults with this common fatty liver disease. The approval has opened a multi-billion dollar opportunity for Madrigal with the American Liver Foundation CEO Lorraine Stiehl calling it a “game-changing” moment. IV. COPD patients get two new treatments — Verona’s Ohtuvayre and Sanofi-Regeneron’s Dupixent The COPD landscape saw remarkable advances in 2024. FDA approved Verona Pharma’s Ohtuvayre, which brings the first new mechanism of action in over two decades for the treatment of COPD. This dual-action, inhaled medication serves as both a bronchodilator and an anti-inflammatory agent, offering a comprehensive approach to symptom management. Adding to this progress, Sanofi and Regeneron’s Dupixent achieved a historic milestone by becoming the first biologic approved for treating COPD. Over 390 million people are living with COPD worldwide. V. Novartis inks 20 deals in 2024, promises over US$ 25 billion in biobucks, lays bets on radiopharmas Novartis has been investing in early-stage science, buying out companies in the sub-US$ 5 billion range. The Swiss drugmaker Novartis inked over 20 deals in 2024, paying over US$ 5.5 billion upfront and promising over US$ 25 billion in biobucks. The company has particularly focused on radiopharmaceuticals and molecular glue degraders. It acquired Mariana Oncology to strengthen its radioligand therapy (RLT) pipeline, and also inked RLT deals with PeptiDream and Ratio Therapeutics. VI. Despite political pressure, FDA rejects first MDMA-assisted therapy to treat PTSD; Lykos faces expanded probe In August, FDA declined to approve an MDMA-assisted therapy from Lykos Therapeutics to treat post-traumatic stress disorder (PTSD). In the lead-up to the FDA decision, 80 members of Congress from both sides of the aisle had urged US President Joe Biden and the FDA to consider further studies on the therapy. Not satisfied with just declining Lykos’ MDMA-assisted therapy for PTSD, FDA had expanded its investigation into the clinical trials that tested it. Lykos CEO Amy Emerson stepped down after reducing its workforce by 75 percent. Additionally, its founder Rick Doblin exited its board. VII. Alzheimer’s gets two new treatments as FDA approves Lilly’s Kisunla, Alpha Cognition’s Zunveyl FDA finally approved Eli Lilly’s Alzheimer’s drug Kisunla in July, after delaying action on it in March. This approval, along with that of Biogen and Eisai’s Leqembi in 2023, mark successes in treating the mind-wasting disease after three decades of failed efforts. FDA also approved Alpha Cognition’s Zunveyl to treat mild-to-moderate Alzheimer’s disease. Zunveyl is a prodrug of Alzheimer’s medication galantamine, and is to be taken orally twice a day. Alpha said Zunveyl is designed to address the tolerability issues with galantamine. VIII. IRA price talks conclude; Stelara, Enbrel, Eliquis to bring 51.4% of Medicare savings After filing futile lawsuits questioning the constitutional validity of the Medicare drug price negotiations under the Inflation Reduction Act (IRA), all drug companies came to the bargaining table. In August, the Biden-Harris Administration announced it had reached agreements for lower prices for all 10 drugs selected for negotiations under the IRA. The new prices come into effect from January 1, 2026. A Brookings Institution report said that just three drugs will account for over half of the expected US$ 6 billion savings in 2026. J&J’s Stelara (US$ 1.4 billion), Amgen’s Enbrel (US$ 1.1 billion), and BMS’ Eliquis (US$ 856 million) are expected to account for US$ 3.28 billion or 51.4 percent of Medicare savings. IX. Trump’s picks for new administration send shockwaves across markets, stocks of vaccine makers tumble  Donald Trump’s picks for his new administration not only created big news, but also impacted the stock markets. His selection of Robert F. Kennedy Jr., an anti-vaccine activist, to lead the Department of Health and Human Services (HHS), sent shares of several vaccine manufacturers plummeting. In the US, stocks of Pfizer, Moderna, and Novavax dipped. In Europe, stocks of BioNTech, GSK, and Bavarian Nordic tumbled. Trump has nominated Mehmet Oz, a celebrity TV host, to run the Centers for Medicare and Medicaid Services (CMS), which oversees health insurance. X. New mpox outbreak in Africa sparks global response; FDA approves Emergent’s vaccine to treat mpox In August, a new mpox virus clade put Africa in the throes of an mpox outbreak. The WHO declared it a public health emergency of international concern. Emergent BioSolutions said it will donate 50,000 doses of its smallpox vaccine ACAM2000. Multiple countries responded with donations of Bavarian Nordic’s Jynneos, the only widely-approved mpox vaccine at the time. In early September, the FDA approved Emergent’s ACAM2000 as the second mpox vaccine.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1799

    https://www.pharmacompass.com/radio-compass-blog/fda-s-landmark-approvals-of-bms-schizo-med-madrigal-s-mash-drug-us-16-5-bn-catalent-buyout-make-it-to-top-10-news-of-2024

    #Phispers by PHARMACOMPASS
    02 Jan 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Abbott Hosts Conference Call for Fourth-Quarter Earnings
    Abbott Hosts Conference Call for Fourth-Quarter Earnings

    02 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-fourth-quarter-earnings-302337311.html

    PR NEWSWIRE
    02 Jan 2025
    Share Share
    Abbott Announce 1st-in-World Leadless Pacing in Left Bundle Branch
    Abbott Announce 1st-in-World Leadless Pacing in Left Bundle Branch

    17 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbott-announces-first-in-world-leadless-pacing-procedures-in-the-left-bundle-branch-area-of-the-heart-302333484.html

    PR NEWSWIRE
    17 Dec 2024
    Share Share
    Abbott Increases Quarterly Dividend for 53rd Consecutive Year
    Abbott Increases Quarterly Dividend for 53rd Consecutive Year

    13 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbott-increases-quarterly-dividend-for-53rd-consecutive-year-302331449.html

    PR NEWSWIRE
    13 Dec 2024
    Share Share
    AdvaMed, Abbott ask FDA to prioritize cybersecurity
    AdvaMed, Abbott ask FDA to prioritize cybersecurity

    11 Dec 2024

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2024/12/advamed,-abbott-ask-fda-to-prioritize-cybersecurit

    RAPS
    11 Dec 2024
    Share Share
    University Of Nebraska Wins Abbott's Blood Drive Competition
    University Of Nebraska Wins Abbott's Blood Drive Competition

    07 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/university-of-nebraska-wins-the-abbott-and-big-ten-conferences-nationwide-we-give-blood-drive-competition-receives-1-million-grant-from-abbott-302325495.html

    PR NEWSWIRE
    07 Dec 2024
    Share Share
    Abbott Launches 14-Valent Pneumococcal Vaccine For Children
    Abbott Launches 14-Valent Pneumococcal Vaccine For Children

    27 Nov 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/abbott-launches-14-valent-pneumonia-vaccine-for-children/articleshow/115733574.cms

    ECONOMICTIMES
    27 Nov 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    9-(s)-erythromycylamine

    U.S.A
    Duphat
    Not Confirmed
    arrow

    02

    Amikacin Sulfate

    U.S.A
    Duphat
    Not Confirmed
    arrow

    03

    Amrinone

    U.S.A
    Duphat
    Not Confirmed
    arrow

    04

    Arbutamine

    U.S.A
    Duphat
    Not Confirmed
    arrow

    05

    Arsanilic Acid (sodium Arsanilate)

    U.S.A
    Duphat
    Not Confirmed
    arrow

    06

    Arsanilic Acid--sodium Arsanilate Wi...

    U.S.A
    Duphat
    Not Confirmed
    arrow

    07

    Atracurium Besylate

    U.S.A
    Duphat
    Not Confirmed
    arrow

    08

    Betaxolol Hydrochloride, Usp

    U.S.A
    Duphat
    Not Confirmed
    arrow

    09

    Bifeprunox Mesylate Bulk Drug Substa...

    U.S.A
    Duphat
    Not Confirmed
    arrow

    10

    Bradykinin Acetate Npc-567

    U.S.A
    Duphat
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact ABBOTT LABORATORIES, LIMITED and get a quotation

    ABBOTT LABORATORIES, LIMITED is a supplier offers 115 products (APIs, Excipients or Intermediates).

    Find a price of Lactulose bulk with DMF, CEP, JDMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Dydrogesterone bulk with CEP, JDMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Verapamil Hydrochloride bulk with DMF, CEP offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Chondroitin Sulfate Sodium bulk with DMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Clarithromycin bulk with CEP offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Lactulose bulk with CEP offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Pancreatin bulk with DMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Thyroid bulk with DMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Trandolapril bulk with CEP offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Zotarolimus bulk with DMF offered by ABBOTT LABORATORIES, LIMITED

    Find a price of 2-Thiouracil bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Amikacin Sulfate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Amrinone bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Atracurium Besylate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Betaxolol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Bifeprunox bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Bradykinin bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Butabarbital bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Butorphanol Tartrate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Carbidopa bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of CAS 50-28-2 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Clindamycin Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Cytolex bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Dicumarol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Diethylstilbestrol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Dimethadione bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Divalproex Sodium bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Dobutamine Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Enflurane bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Erythromycin bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Erythromycin Estolate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Erythromycin Ethyl Succinate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Erythromycin Stearate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Erythromyclamine bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Ethchlorvynol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Fentanyl bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Fentanyl Citrate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Genesa bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Glipizide bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Gonadorelin Acetate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Haloperidol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Hydrochlorothiazide bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Hydroxychloroquine Sulphate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Inositol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Iopamidol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Ketorolac Trometamol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Lincomycin Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Lovastatin bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MAPROTILINE HYDROCHLORIDE bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Meprobamate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Methocarbamol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Methyclothiazide bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Methylprednisolone Hemisuccinate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Midazolam bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Oxtriphylline bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Oxybutynin Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Paracetamol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Pentamidine Isethionate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Pentetic Acid bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Pentigide bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Prazosin Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Propofol bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Propoxyphene Napsylate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Selenium Sulfide bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Simethicone bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Sirolimus bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Sodium Arsanilate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Spectinomycin bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Spectinomycin Dihydrochloride Pentahydrate bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Succinylcholine Chloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Sulfiram bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Terazosin HCl bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Tetracycline bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Thiamylal bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Thyrotropin-Releasing Hormone bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Tromethamine API bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Tubocurarine Chloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Vancomycin Hydrochloride bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Verapamil bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of Vitamin K1 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of CURRICULUM VITAE OF ABBOTT'S THERAPEUTIC COMMITTEE bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of METHAPYRILENE HCL bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ROCKY MOUNT, NORTH CAROLINA. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN NORTH CHICAGO, ILLINOIS. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of NIKKOMYCIN Z HYDROCHLORIDE bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of SPEC, STANDARD CONTROL PROCEDS & TEXT METHODS FOR INACTIVE INGREDS. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of STANDARD TEST METHODS FOR TESTING SVP & LVP PRODUCTS (5-1-80 - 5-1-81) bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILITIES AND OPERATING PROCEDURES IN LATINA, ITALY (LABORATORI ABBOTT S.P.A.) bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILITIES bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MCPHERSON, KANSAS. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of RENAL KETO ACID PRODUCT bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILITIES LOCATED IN QUEENBOROUGH, KENT, UK bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of I-125-FIBRINOGEN (HUMAN) SENSOR bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of 2-(2-FORMYLHYDRAZINO)-4-(5-NITRO-2-FURYL)-THIAZOLE (AS-L7665)&A-2L203 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MFGR PROCEDS,CTRLS,FACILS & PACKAGING P.RICO PLANT bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUF, PACKAGING AND LABELING OF BULK CALCIUM AND SODIUM CYCLAMATE bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILS, PERSONNEL & GEN OPER PROCEDS FOR THE MURINE CO. FACILS. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE,FACILITES,PERSONNEL, AND GENERAL MANUFACTURING PROCEDURES. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of STD CONTROL PROCEDURES,RAW DRUG CODES FOR SVP & LVP PRODUCTS,5-80 5-81 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of STD TEST METHODS FOR TESTING SVP & LVP PRODUCTS(PERIOD 5-1-80 - 5-1-81 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ETHRANE IN QUEENBOUROUGH, KENT, ENGLAND. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of IRON-58 STERILE SOLUTION bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of LIFE CARE FLEXIBLE CONTAINERS bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN QUEENBOURGH, KENT, UNITED KINGDOM. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of QUALITY ASSURANCE OPERATION STANDARDS bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of M-259 (NSC 51954) bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of ABBOTT LABS QUALITY ASSURANCE OPERATIONS STANDARDS MANUAL PHARM. DIV. bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of CYCLAMATE, SACCHARIN AND CYCLOHEXYLAMINE bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of QUALITY ASSURANCE OPERATIONS STANDARDS bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of STD.CONTROL PROCEDURES,RAW DRUG CODES FOR SVP & LVP PRODUCTS(5-80 5-81 bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of SEMI-WORKS AREA IN QUEENBOROUGH, KENT, UNITED KINGDOM bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILS., PROCEDS., & CONTROLS-AT THE BARCELONETA, PUERTO RICO PLANT bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of FACILITIES AND OPERATING PROCEDURES IN QUEENBOROUGH, ENGLAND bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of ANTIBIOTIC M-188 (MACROLIDE ANTIBIOTIC OF THE ERYTHROMYCIN GROUP) bulk offered by ABBOTT LABORATORIES, LIMITED

    Find a price of DEXOXYEPHEDRINE HCL bulk offered by ABBOTT LABORATORIES, LIMITED

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search